Clinical Trial Update: A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thymosin beta-4 for wound healing in epidermolysis bullosa was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• Thymosin beta-4 (thymosin beta-4)

Snippet

Sponsor: RegeneRx Biopharmaceuticals, Inc. | Conditions: Epidermolysis Bullosa | Phase 2 | Status: TERMINATED | Results posted: 2013-06-10